Position in ALKS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$66,553,812
+$3,106,702 QoQ
Shares Held
1,882,178
-17.0% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 96.06631253792149.ToString("F0")%
Shared 0.ToString("F0")%
None 3.933687462078507.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Derivatives in ALKS
reported options exposure · as of Jun 30, 2025CallValue
$1,195,898
CallShares
41,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $1,741,757,397 across 53 Drug Manufacturers - Specialty & Generic names. ALKS ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,730,785 | $441,016,092 | |
| 2 | VTRS |
Viatris Inc
|
13,717,622 | $185,325,071 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,826,245 | $145,366,498 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
5,618,728 | $104,058,841 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,409,165 | $73,431,349 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
114,419 | $67,848,177 | |
| 7 | ALKS |
Alkermes plc.
This page
|
1,882,178 | $66,553,812 | |
| 8 | HLN |
Haleon plc
|
6,127,452 | $61,335,793 |
All Filings in ALKS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,553,812 | 1,882,178 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $63,447,110 | 2,267,588 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $59,848,350 | 1,994,945 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,195,898 | 41,800 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $47,712,809 | 1,667,697 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $48,607,120 | 1,472,051 | Shares | Defined | 2025-06-27 | |
| 2025-03-31 | $561,340 | 17,000 | Put | Defined | 2025-06-27 | |
| 2024-12-31 | $41,494,811 | 1,442,796 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $48,874,933 | 1,746,157 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $862,092 | 30,800 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $29,840,040 | 1,238,176 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $37,501,342 | 1,385,347 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $38,914,197 | 1,402,819 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $53,964,736 | 1,926,624 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $51,456,072 | 1,643,964 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $37,810,344 | 1,341,268 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $48,756,149 | 1,865,907 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $46,992,881 | 2,104,473 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $68,034,342 | 2,283,798 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $60,120,480 | 2,285,081 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $45,798,148 | 1,968,966 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $58,395,940 | 1,893,513 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $46,029,679 | 1,877,230 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $16,478,747 | 882,160 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $35,630,360 | 1,785,983 | Shares | Defined | 2021-02-12 | |
| 2020-06-30 | $34,128,855 | 1,758,313 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $21,496,499 | 1,490,742 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||